NTRS - NASA Technical Reports Server

Back to Results
Update on the incidence and treatment of space motion sicknessFlight surgeons routinely monitor crew symptoms and treatment of space motion sickness (SMS), not only during flight, but also to obtain information postflight from each crewmember. Recent statistics indicate that the incidence of SMS has not changed since STS-26 in Sep. 1988. The percentages of mild, moderate, and severe cases has only changed slightly. However, the treatment of SMS has significantly changed since STS-26. Scopolamine/dexedrine is no longer used as a prophylaxis for SMS symptoms because of evidence of delay in symptoms. Intramuscular promethazine has been used in more than 30 individuals with a reported decrease in symptoms greater than 90 percent. A delay in symptoms has not been reported, and the duration of certain SMS symptoms has decreased due to use of intramuscular promethazine. Case studies will be discussed and several therapeutic options and doses will be demonstrated. Further treatment possibilities will be examined.
Document ID
Document Type
Conference Paper
Beck, Bradley G. (NASA Lyndon B. Johnson Space Center Houston, TX, United States)
Date Acquired
September 6, 2013
Publication Date
February 1, 1993
Publication Information
Publication: Sixth Annual Workshop on Space Operations Applications and Research (SOAR 1992), Volume 2
Subject Category
Distribution Limits
Work of the US Gov. Public Use Permitted.

Related Records

IDRelationTitle19940007055Analytic PrimarySixth Annual Workshop on Space Operations Applications and Research (SOAR 1992), volume 2